Inès Dufait

811 total citations
33 papers, 618 citations indexed

About

Inès Dufait is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Inès Dufait has authored 33 papers receiving a total of 618 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 15 papers in Immunology and 10 papers in Molecular Biology. Recurrent topics in Inès Dufait's work include Cancer Immunotherapy and Biomarkers (11 papers), Immunotherapy and Immune Responses (11 papers) and CAR-T cell therapy research (10 papers). Inès Dufait is often cited by papers focused on Cancer Immunotherapy and Biomarkers (11 papers), Immunotherapy and Immune Responses (11 papers) and CAR-T cell therapy research (10 papers). Inès Dufait collaborates with scholars based in Belgium, United Kingdom and Spain. Inès Dufait's co-authors include Mark De Ridder, Karine Breckpot, David Escors, Thérèse Liechtenstein, Heng Jiang, Julia Katharina Schwarze, Alessio Lanna, Sven de Mey, Thierry Gevaert and Lun Law Ka and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and International Journal of Molecular Sciences.

In The Last Decade

Inès Dufait

30 papers receiving 613 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Inès Dufait Belgium 17 277 259 241 119 80 33 618
Midan Ai United States 9 326 1.2× 322 1.2× 178 0.7× 181 1.5× 70 0.9× 13 627
Paige J. Baugher United States 6 295 1.1× 411 1.6× 268 1.1× 89 0.7× 45 0.6× 7 684
Sofia Depner Germany 12 202 0.7× 227 0.9× 330 1.4× 127 1.1× 46 0.6× 12 641
Jesús Anampa United States 7 117 0.4× 415 1.6× 242 1.0× 230 1.9× 121 1.5× 14 746
Pranita Atri United States 16 142 0.5× 346 1.3× 379 1.6× 178 1.5× 84 1.1× 33 674
Ryuhjin Ahn Canada 11 155 0.6× 246 0.9× 219 0.9× 87 0.7× 62 0.8× 17 444
Raefa Abou Khouzam United Arab Emirates 12 148 0.5× 179 0.7× 201 0.8× 224 1.9× 87 1.1× 21 501
Gabriela Raso United States 5 161 0.6× 243 0.9× 215 0.9× 104 0.9× 186 2.3× 6 532
Viola Allaj United States 6 163 0.6× 352 1.4× 282 1.2× 138 1.2× 87 1.1× 12 619
Guangshun Sun China 16 168 0.6× 230 0.9× 478 2.0× 271 2.3× 120 1.5× 27 790

Countries citing papers authored by Inès Dufait

Since Specialization
Citations

This map shows the geographic impact of Inès Dufait's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inès Dufait with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inès Dufait more than expected).

Fields of papers citing papers by Inès Dufait

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inès Dufait. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inès Dufait. The network helps show where Inès Dufait may publish in the future.

Co-authorship network of co-authors of Inès Dufait

This figure shows the co-authorship network connecting the top 25 collaborators of Inès Dufait. A scholar is included among the top collaborators of Inès Dufait based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inès Dufait. Inès Dufait is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Montay‐Gruel, Pierre, et al.. (2025). Exploring the Metabolic Impact of FLASH Radiotherapy. Cancers. 17(1). 133–133. 7 indexed citations
2.
Dufait, Inès, et al.. (2024). Ferroptosis: Frenemy of Radiotherapy. International Journal of Molecular Sciences. 25(7). 3641–3641. 13 indexed citations
3.
4.
Corbet, Cyril, et al.. (2024). Revisiting hydrogen peroxide as radiosensitizer for solid tumor cells. Radiotherapy and Oncology. 203. 110692–110692.
5.
Shintouo, Cabirou Mounchili, et al.. (2023). Heat shock proteins and cellular senescence in humans: A systematic review. Archives of Gerontology and Geriatrics. 113. 105057–105057. 9 indexed citations
6.
Baker, Kristi, Inès Dufait, Jashodeep Datta, et al.. (2023). Colorectal Cancer Immunotherapy: State of the Art and Future Directions. SHILAP Revista de lepidopterología. 2(8). 1103–1119. 21 indexed citations
7.
Dufait, Inès, et al.. (2022). Unraveling the biological meaning of radiomic features. VUBIR (Vrije Universiteit Brussel). 1–6. 5 indexed citations
8.
Dufait, Inès, Julia Katharina Schwarze, Ivan Van Riet, et al.. (2021). Unraveling the Effects of a Talimogene Laherparepvec (T-VEC)-Induced Tumor Oncolysate on Myeloid Dendritic Cells. Frontiers in Immunology. 12. 733506–733506. 7 indexed citations
9.
Mey, Sven de, Inès Dufait, & Mark De Ridder. (2021). Radioresistance of Human Cancers: Clinical Implications of Genetic Expression Signatures. Frontiers in Oncology. 11. 761901–761901. 22 indexed citations
10.
Schwarze, Julia Katharina, Johnny Duerinck, Inès Dufait, et al.. (2020). A phase I clinical trial on intratumoral and intracavitary administration of ipilimumab and nivolumab in patients with recurrent glioblastoma.. Journal of Clinical Oncology. 38(15_suppl). 2534–2534. 8 indexed citations
11.
Schwarze, Julia Katharina, Gil Awada, Inès Dufait, et al.. (2019). A phase I clinical trial on intratumoral administration of autologous CD1c (BDCA-1)+ myeloid dendritic cells plus talimogene laherparepvec (T-VEC) in patients with advanced melanoma. VUBIR (Vrije Universiteit Brussel). 7.
12.
Mey, Sven de, Heng Jiang, Cyril Corbet, et al.. (2018). Antidiabetic Biguanides Radiosensitize Hypoxic Colorectal Cancer Cells Through a Decrease in Oxygen Consumption. Frontiers in Pharmacology. 9. 1073–1073. 32 indexed citations
13.
Mey, Sven de, Heng Jiang, Hui Wang, et al.. (2018). Potential of memory T cells in bridging preoperative chemoradiation and immunotherapy in rectal cancer. Radiotherapy and Oncology. 127(3). 361–369. 4 indexed citations
14.
Dufait, Inès, Julia Katharina Schwarze, Lun Law Ka, et al.. (2016). Myeloid-derived suppressor cells reveal radioprotective properties through arginase-induced l-arginine depletion. Radiotherapy and Oncology. 119(2). 291–299. 33 indexed citations
15.
Dufait, Inès, Julia Katharina Schwarze, Thérèse Liechtenstein, et al.. (2015). Ex vivogeneration of myeloid-derived suppressor cells that model the tumor immunosuppressive environment in colorectal cancer. Oncotarget. 6(14). 12369–12382. 57 indexed citations
16.
Liechtenstein, Thérèse, Idoia Blanco‐Luquin, Cleo Goyvaerts, et al.. (2014). Anti-melanoma vaccines engineered to simultaneously modulate cytokine priming and silence PD-L1 characterized usingex vivomyeloid-derived suppressor cells as a readout of therapeutic efficacy. OncoImmunology. 3(7). e945378–e945378. 35 indexed citations
17.
Escors, David, Thérèse Liechtenstein, Julia Katharina Schwarze, et al.. (2013). Assessing T-cell responses in anticancer immunotherapy. OncoImmunology. 2(10). e26148–e26148. 23 indexed citations
18.
Liechtenstein, Thérèse, Christopher Bricogne, Alessio Lanna, et al.. (2013). Immune modulation by genetic modification of dendritic cells with lentiviral vectors. Virus Research. 176(1-2). 1–15. 18 indexed citations
19.
Liechtenstein, Thérèse, Inès Dufait, Alessio Lanna, Karine Breckpot, & David Escors. (2012). Modulating Co-Stimulation During Antigen Presentation to Enhance Cancer Immunotherapy. Immunology Endocrine & Metabolic Agents - Medicinal Chemistry. 12(3). 224–235. 39 indexed citations
20.
Dufait, Inès, Thérèse Liechtenstein, Alessio Lanna, et al.. (2012). Retroviral and Lentiviral Vectors for the Induction of Immunological Tolerance. Scientifica. 2012. 1–14. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Midan Ai Breakdown of academic impact, for papers by Paige J. Baugher Breakdown of academic impact, for papers by Sofia Depner Breakdown of academic impact, for papers by Jesús Anampa Breakdown of academic impact, for papers by Pranita Atri Breakdown of academic impact, for papers by Ryuhjin Ahn Breakdown of academic impact, for papers by Raefa Abou Khouzam Breakdown of academic impact, for papers by Gabriela Raso Breakdown of academic impact, for papers by Viola Allaj Breakdown of academic impact, for papers by Guangshun Sun
Rankless by CCL
2026